WO2004002425A3 - Methodes permettant d'ameliorer l'acceptation d'une greffe par depletion des cellules souches hematopoietiques - Google Patents
Methodes permettant d'ameliorer l'acceptation d'une greffe par depletion des cellules souches hematopoietiques Download PDFInfo
- Publication number
- WO2004002425A3 WO2004002425A3 PCT/US2003/020520 US0320520W WO2004002425A3 WO 2004002425 A3 WO2004002425 A3 WO 2004002425A3 US 0320520 W US0320520 W US 0320520W WO 2004002425 A3 WO2004002425 A3 WO 2004002425A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- stem cells
- hematopoietic stem
- depletion
- depleting
- inactivating
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2003245752A AU2003245752A1 (en) | 2002-06-28 | 2003-06-27 | Process for promoting graft acceptance by depletion of hematopoietic stem cells |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US39259002P | 2002-06-28 | 2002-06-28 | |
US60/392,590 | 2002-06-28 | ||
US35770603A | 2003-02-04 | 2003-02-04 | |
US10/357,706 | 2003-02-04 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2004002425A2 WO2004002425A2 (fr) | 2004-01-08 |
WO2004002425A3 true WO2004002425A3 (fr) | 2004-08-26 |
Family
ID=30002887
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2003/020520 WO2004002425A2 (fr) | 2002-06-28 | 2003-06-27 | Methodes permettant d'ameliorer l'acceptation d'une greffe par depletion des cellules souches hematopoietiques |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2003245752A1 (fr) |
WO (1) | WO2004002425A2 (fr) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP7181203B2 (ja) | 2016-12-21 | 2022-11-30 | ノバルティス アーゲー | 造血幹細胞を除去するための抗体薬物結合体 |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3255061B1 (fr) * | 2006-11-03 | 2021-06-16 | The Board of Trustees of the Leland Stanford Junior University | Immunodéplétion sélective de niche de cellules souches endogènes pour greffe |
JP2012505193A (ja) | 2008-10-10 | 2012-03-01 | プロベルテ ファーマ,エス.エー. | 水産養殖用経口投与免疫賦活剤 |
US9156912B2 (en) * | 2008-12-12 | 2015-10-13 | The University Of Tokyo | Immunological reconstitution promoter or prophylactic agent for infections each of which maintains graft-versus-tumor effect |
EP3763740A1 (fr) | 2011-01-26 | 2021-01-13 | Celldex Therapeutics, Inc. | Anticorps anti-kit et leurs utilisations |
EP4063391A1 (fr) | 2012-07-25 | 2022-09-28 | Celldex Therapeutics, Inc. | Anticorps anti-kit et leurs utilisations |
WO2015050959A1 (fr) * | 2013-10-01 | 2015-04-09 | Yale University | Anticorps anti-kits et leurs méthodes d'utilisation |
EP3145543A4 (fr) | 2014-05-23 | 2017-12-13 | Celldex Therapeutics, Inc. | Traitement des affections associées aux éosinophiles ou aux mastocytes |
US20170209447A1 (en) * | 2014-08-07 | 2017-07-27 | Nitor Therapeutics | Use of PNP Inhibitor to Treat Relapse of Malignancy after Hematopoietic Stem Cell Transplant |
EP4257145A3 (fr) | 2014-08-26 | 2023-10-18 | The Board of Trustees of the Leland Stanford Junior University | Greffe de cellules souches avec combinaison d'un agent ciblant des cellules souches et modulation de la signalisation immunorégulatrice |
AU2016246707B2 (en) | 2015-04-06 | 2021-03-25 | President And Fellows Of Harvard College | Compositions and methods for non-myeloablative conditioning |
AU2016310348B2 (en) | 2015-08-26 | 2023-01-05 | The Board Of Trustees Of The Leland Stanford Junior University | Enhanced depletion of targeted cells with CD47 blockade and an immune costimulatory agonist |
KR20230066647A (ko) | 2016-06-17 | 2023-05-16 | 마젠타 테라퓨틱스 인코포레이티드 | Cd117+ 세포의 고갈을 위한 조성물 및 방법 |
US20200188527A1 (en) * | 2017-03-31 | 2020-06-18 | The Children's Medical Center Corporation | Antibody-mediated conditioning with immunosuppression to enable allogeneic transplantation |
UY38265A (es) * | 2018-06-20 | 2020-01-31 | Novartis Ag | Conjugados anticuerpo droga para ablación de células madre hematopoyéticas |
EP3886869A4 (fr) | 2018-11-28 | 2022-07-06 | Forty Seven, Inc. | Csph génétiquement modifiées résistantes au traitement ablatif |
WO2020219861A1 (fr) * | 2019-04-25 | 2020-10-29 | Actinium Pharmaceuticals, Inc. | Compositions et procédés d'immunodéplétion pour le traitement des maladies hématologiques malignes et non malignes |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998007444A1 (fr) * | 1996-08-16 | 1998-02-26 | Biotransplant, Inc. | ANTICORPS LO-CD2a ET SON UTILISATION POUR INHIBER L'ACTIVATION ET LA PROLIFERATION DE CELLULES T |
WO2001025398A2 (fr) * | 1999-10-01 | 2001-04-12 | Biotransplant Incorporated | Technique permettant d'induire une tolerance fonctionnelle a des produits de transfert genique |
WO2001030369A1 (fr) * | 1999-10-22 | 2001-05-03 | Biotransplant, Inc. | Procede d'induction d'une tolerance immunologique pour des greffons heterologues |
WO2001087310A1 (fr) * | 2000-05-18 | 2001-11-22 | Biotransplant, Inc. | Procede de reduction de la reponse anticorps contre des xenogreffes |
WO2002033043A2 (fr) * | 2000-10-18 | 2002-04-25 | Coriell Institute For Medical Research | Methode et marqueur d'isolement de cellules souches humaines hematopoietiques multipotentes |
-
2003
- 2003-06-27 AU AU2003245752A patent/AU2003245752A1/en not_active Abandoned
- 2003-06-27 WO PCT/US2003/020520 patent/WO2004002425A2/fr not_active Application Discontinuation
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998007444A1 (fr) * | 1996-08-16 | 1998-02-26 | Biotransplant, Inc. | ANTICORPS LO-CD2a ET SON UTILISATION POUR INHIBER L'ACTIVATION ET LA PROLIFERATION DE CELLULES T |
WO2001025398A2 (fr) * | 1999-10-01 | 2001-04-12 | Biotransplant Incorporated | Technique permettant d'induire une tolerance fonctionnelle a des produits de transfert genique |
WO2001030369A1 (fr) * | 1999-10-22 | 2001-05-03 | Biotransplant, Inc. | Procede d'induction d'une tolerance immunologique pour des greffons heterologues |
WO2001087310A1 (fr) * | 2000-05-18 | 2001-11-22 | Biotransplant, Inc. | Procede de reduction de la reponse anticorps contre des xenogreffes |
WO2002033043A2 (fr) * | 2000-10-18 | 2002-04-25 | Coriell Institute For Medical Research | Methode et marqueur d'isolement de cellules souches humaines hematopoietiques multipotentes |
Non-Patent Citations (3)
Title |
---|
BUHLER L. ET AL: "High-dose porcine hematopoietic cell transplantation combined with CD40 ligand blockade in baboons prevents an induced anti-pig humoral response", TRANSPLANTATION, vol. 69, no. 11, 15 June 2000 (2000-06-15), pages 2296 - 2304, XP002978334 * |
BUHLER L. ET AL: "Pig hematopoietic cell chimerism in baboons conditioned with a nonmyeloablative regimen and CD154 blockade", TRANSPLANTATION, vol. 73, no. 1, 15 January 2002 (2002-01-15), pages 12 - 22, XP002978708 * |
GIOVINO MA ET AL: "Porcine hematopoiesis on primate stroma in long-term cultures: enhanced growth with neutralizing tumor necrosis factor-alpha and tumor growth factor-beta antibodies", TRANSPLANTATION, vol. 73, no. 5, 15 March 2002 (2002-03-15), pages 723 - 731, XP002978373 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP7181203B2 (ja) | 2016-12-21 | 2022-11-30 | ノバルティス アーゲー | 造血幹細胞を除去するための抗体薬物結合体 |
Also Published As
Publication number | Publication date |
---|---|
AU2003245752A1 (en) | 2004-01-19 |
WO2004002425A2 (fr) | 2004-01-08 |
AU2003245752A8 (en) | 2004-01-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2004002425A3 (fr) | Methodes permettant d'ameliorer l'acceptation d'une greffe par depletion des cellules souches hematopoietiques | |
Carlson et al. | Platelet-rich plasma: clinical applications in dentistry | |
Kitoh et al. | Transplantation of marrow-derived mesenchymal stem cells and platelet-rich plasma during distraction osteogenesis—a preliminary result of three cases | |
Connolly | Injectable bone marrow preparations to stimulate osteogenic repair | |
Kawasumi et al. | The effect of the platelet concentration in platelet-rich plasma gel on the regeneration of bone | |
WO2005011569A3 (fr) | Methodes comprenant l'utilisation de cellules derivees du tissu adipeux pour le transfert de graisse autologue a des fins d'augmentation | |
Andia et al. | Current concepts and translational uses of platelet rich plasma biotechnology | |
AU5439400A (en) | Autologous thrombin | |
AU697761B2 (en) | Decontaminating blood components with 8-methoxypsoralen | |
De Fabritiis et al. | Elimination of clonogenic Burkitt's lymphoma cells from human bone marrow using 4-hydroperoxycyclophosphamide in combination with monoclonal antibodies and complement | |
DE69922362D1 (de) | Methode zur präparation eines diafiltrierten stabilen blutproduktes | |
WO2002064748A3 (fr) | Cellules souches adultes totipotentes, sources de ces cellules, procedes d'obtention et de maintien de ces dernieres, procedes de differentiation de ces cellules, procedes d'utilisation correspondants et cellules derivees des cellules susmentionnees | |
WO1999046366A8 (fr) | Utilisations de cellules souches humaines mesenchymateuses non autologues | |
MY122383A (en) | Cyclic boroproline compounds | |
EP1077254A3 (fr) | Potentialités de différenciation en multiples lignées cellulaires mésodermiques pour des cellules de stroma dérivées de tissu adipeux et leurs applications | |
EP2233150A3 (fr) | Erythropoietin pour utilisation dans la guérison de blessures ou la transplantation de cellules | |
NO20060498L (no) | Metode for a promotere benvekst | |
WO1999003976A3 (fr) | Traitement des leucocytes, compositions leucocytaires, et leur procede d'utilisation | |
WO2000040269A3 (fr) | Compositions pharmaceutiques destinees au traitement des tissus malades | |
ATE300310T1 (de) | Verfahren zur steigerung von hematopoietischen zellen | |
ATE211927T1 (de) | Verfahren zur virusinaktivierung in gegenwart eines polyethers und eines agens | |
EP1890713B1 (fr) | Composition osteoblastique a base de fibrine melangee semi-solidifiee utilisee pour produire une agglutination en cas de fracture osseuse et son procede de production | |
EP1578958A4 (fr) | Procede de suppression de la reponse du systeme immunitaire a des tissus ou des cellules greffes | |
WO2005017160A3 (fr) | Mobilisation de cellules hematopoietques | |
WO2001094586A3 (fr) | Anticorps non agonistiques diriges contre gp 39 humaine, compositions les contenant et leur utilisation therapeutique |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: JP |